Sandoz Teriflunomide 14 mg (Teriflunomide TABLET) 14 MG

Sandoz Teriflunomide 14 mg tablets are a prescription medication used to manage multiple sclerosis. This oral treatment is designed to help reduce relapses and slow disease progression.

Strength

14 MG

Manufacturer / TM Owner

SANDOZ CANADA INCORPORATED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Teriflunomide is primarily used in the treatment of relapsing forms of multiple sclerosis. It works by modulating the immune system to reduce inflammation and damage to the nervous system. Patients often wonder, 'What is teriflunomide used for?' This medication is specifically indicated for individuals with relapsing multiple sclerosis to help manage symptoms and slow the progression of the disease.

Side Effects

Common effects of teriflunomide may include hair loss, diarrhea, and mild nausea. Some users also report fatigue or headaches. These effects can vary widely among individuals and are not experienced by everyone taking the medication.

Precautions & Warnings

Teriflunomide should be handled with care, especially during pregnancy, as it can cause harm to a developing fetus. It is important to discuss any pre-existing conditions or other medications with a healthcare provider before starting teriflunomide. Regular monitoring may be required to ensure safety and effectiveness.

Avoid Interactions

Teriflunomide can interact with a variety of medications, including those that affect the immune system or liver function. Alcohol and certain other substances may also interact with teriflunomide, so it is important to consult with a healthcare provider about potential interactions.

Frequently Asked Questions

Teriflunomide is used to treat relapsing forms of multiple sclerosis by modulating the immune system to reduce inflammation and damage.

Teriflunomide is typically taken orally, usually once daily. Follow the specific instructions provided by your healthcare provider.

Common side effects may include hair loss, diarrhea, nausea, fatigue, and headaches. Not everyone experiences these effects.

Teriflunomide should be avoided during pregnancy due to potential risks to the developing fetus. Consult a healthcare provider for guidance.

The onset of action can vary. Some patients may see effects within a few weeks, while others may take longer to notice improvements.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.